Sunday, November 11, 2012

Cancer Survivors With Chronic Dry Mouth Benefit From First Human Gene Therapy Study In Human Salivary Glands

Gene therapy can be performed safely in the human salivary gland, according to scientists at the National Institute of Dental and Craniofacial Research (NIDCR), part of the National Institutes of Health. This finding comes from the first-ever safety, or Phase I, clinical study of gene therapy in a human salivary gland. Its results, published this week in the Proceedings of the National Academy of Sciences, also show that the transferred gene, Aquaporin-1, has great potential to help head and neck cancer survivors who battle with chronic dry mouth.

Source: http://www.dentapress.com/headlines/4713-cancer-survivors-with-chronic-dry-mouth-benefit-from-first-human-gene-therapy-study-in-human-salivary-glands-2.html

dental oral surgeons maxillofacial surgeon oral maxillofacial surgeon oral and maxillofacial surgeon dentistry oral surgery

No comments:

Post a Comment